FIELD: medicine, endocrinology, pharmacy.
SUBSTANCE: invention relates to treatment of diabetes mellitus and complications associated with diabetes mellitus. Invention proposes using a pharmaceutical composition for prophylaxis and treatment of diabetes mellitus and associated complications. Pharmaceutical composition comprises an enhancer for sensitivity to insulin (but excluding troglitazone) in combination with at least component from group consisting of aldose reductase inhibitor, biguanide, statin compound and angiotensin-converting enzyme inhibitor. Proposed pharmaceutical composition offers the strong inhibitory effect with respect to diabetic hyperglycemia.
EFFECT: valuable medicinal properties of pharmaceutical composition.
30 cl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2198682C2 |
| METHOD OF PREVENTION AND TREATMENT AND RELATED COMPLICATION | 1996 |
|
RU2327455C2 |
| METHODS FOR PROPHYLAXIS AND TREATMENT, APPLICATION OF AGENT TO ENHANCE INSULIN SUSCEPTIBILITY | 2003 |
|
RU2286148C2 |
| PANCREATIC DIABETES DRUG | 2004 |
|
RU2358738C2 |
| METHOD FOR PROPHYLAXIS AND TREATMENT, USING ENHANCER FOR INSULIN SENSIBILITY | 1996 |
|
RU2223760C2 |
| PHARMACEUTICAL COMPOSITIONS | 2010 |
|
RU2532330C2 |
| METHOD FOR TREATMENT OF IMPAIRED GLUCOSE TOLERANCE | 2001 |
|
RU2281094C2 |
| APPLICATION OF THIAZOLIDINEDIONES FOR PREVENTION OR ONSET POSTPONEMENT OF INSULIN-INDEPENDENT DIABETES MELLITUS (NIDDM) | 1994 |
|
RU2195282C2 |
| CONDENSED HETEROCYCLIC DERIVATIVES MEDICAL COMPOSITIONS CONTAINING THEM AND THEIR MEDICAL APPLICATION | 2005 |
|
RU2387663C2 |
| COMBINED THERAPY INCLUDING SGLT INHIBITORS AND DPP4 INHIBITORS | 2009 |
|
RU2481106C2 |
